Capricor Therapeutics, Inc. (CAPR:NASDAQ) closed at $6.13 on October 22, 2026, up 4.25% on the day. The stock trades 84.8% below its 52-week high of $40.37 and 107.1% above its 52-week low of $2.96. Capricor Therapeutics, Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since October 22, 2025, CAPR closed higher on 114 days (45%). Its best day was December 3, 2025 (+371.07%) and its worst was July 27, 2026 (-64.47%). The stock moved 10% or more in a single session 27 times. It opened at least 5% above the previous day's high 6 times.
Capricor Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of novel therapeutics primarily for the treatment of cardiovascular diseases. The company's development stage drug candidates for cardiovascular diseases include CAP-1002 that is in Phase II clinical trials; and CAP-2003, which is in pre-clinical development for the treatment of certain cardiac and inflammatory conditions. The company was founded in 2005 and is headquartered in Beverly Hills, California.
Find more stocks like CAPR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.